Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN) (Coordinating Center).
Withdrawn prior to enrolment
Phase of Trial: Phase I/II
Latest Information Update: 18 Nov 2014
At a glance
- Drugs Erlotinib (Primary) ; Linsitinib (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 08 Jan 2013 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
- 29 Jun 2012 Status changed from suspended to recruiting as reported by ClinicalTrials.gov.